| 26.1 0.6 (2.35%) | 08-19 11:23 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 30.62 |
1-year : | 35.76 |
| Resists | First : | 26.21 |
Second : | 30.62 |
| Pivot price | 23.22 |
|||
| Supports | First : | 21.2 |
Second : | 18.1 |
| MAs | MA(5) : | 25.2 |
MA(20) : | 22.27 |
| MA(100) : | 18.67 |
MA(250) : | 18.26 |
|
| MACD | MACD : | 1.5 |
Signal : | 1.2 |
| %K %D | K(14,3) : | 94.7 |
D(3) : | 93.1  |
| RSI | RSI(14): 81.2 |
|||
| 52-week | High : | 26.21 | Low : | 14.42 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ KIDS ] has closed below upper band by 13.9%. Bollinger Bands are 150.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 25.58 - 25.71 | 25.71 - 25.84 |
| Low: | 24.04 - 24.16 | 24.16 - 24.29 |
| Close: | 25.29 - 25.5 | 25.5 - 25.71 |
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Tue, 18 Aug 2026
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates - Eastern Progress
Tue, 18 Aug 2026
OrthoPediatrics (NASDAQ:KIDS) Sets New 1-Year High - Here's Why - MarketBeat
Mon, 17 Aug 2026
AIGH Capital Management LLC Takes Position in OrthoPediatrics Corp. $KIDS - MarketBeat
Fri, 14 Aug 2026
OrthoPediatrics Sees ‘Inflection Point’ as New Products Fuel Record Quarter - TradingView
Fri, 07 Aug 2026
OrthoPediatrics Corp. (KIDS) Investor Outlook: A 10.97% Potential Upside with Solid Buy Ratings - DirectorsTalk Interviews
Tue, 04 Aug 2026
Nearly 46,000 children helped as OrthoPediatrics revenue hits $70.5M - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 26 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 32.3 (%) |
| Held by Institutions | 64.3 (%) |
| Shares Short | 881 (K) |
| Shares Short P.Month | 849 (K) |
| EPS | -1.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.15 |
| Profit Margin | -15.8 % |
| Operating Margin | -5.8 % |
| Return on Assets (ttm) | -2.8 % |
| Return on Equity (ttm) | -11.4 % |
| Qtrly Rev. Growth | 15.3 % |
| Gross Profit (p.s.) | 7.12 |
| Sales Per Share | 9.67 |
| EBITDA (p.s.) | -0.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 7 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | -15.48 |
| PEG Ratio | 0 |
| Price to Book value | 1.97 |
| Price to Sales | 2.68 |
| Price to Cash Flow | 91.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|